MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- RELIGARE ENT.
- RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%
RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%
Fri, 22 Feb
RELIGARE ENT. has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:
RELIGARE ENT. Quarterly Financials
| No. of Mths Qtr. Ending | 3 Dec-17* | 3 Sep-18* | 3 Dec-18* | QoQ Change | YoY Change | |
|---|---|---|---|---|---|---|
| Net Sales | Rs m | 78 | 13 | 8 | -40.4% | -90.1% |
| Other income | Rs m | 1 | 101 | 115 | 12.8% | 8575.0% |
| Turnover | Rs m | 80 | 115 | 122 | 6.8% | 53.5% |
| Expenses | Rs m | 364 | 107 | 108 | 1.2% | -70.3% |
| Gross profit | Rs m | -286 | -94 | -100 | ||
| Depreciation | Rs m | 5 | 2 | 2 | -10.9% | -60.7% |
| Interest | Rs m | 127 | 134 | 116 | -13.7% | -9.3% |
| Profit before tax | Rs m | -417 | -128 | -103 | ||
| Tax | Rs m | 0 | 0 | 0 | 0.0% | 0.0% |
| Profit after tax | Rs m | -417 | -128 | -103 | ||
| Gross profit margin | % | -364.5 | -716.2 | -1,285.9 | ||
| Effective tax rate | % | 0.0 | 0.0 | 0.0 | ||
| Net profit margin | % | -523.1 | -112.1 | -84.4 |
Interim results exclude extraordinary / exceptional items
Year-on-Year Performance:
- The company's operating income during the quarter fell 90.1% on a year-on-year (YoY) basis. The expenses were down by 70.3% YoY during the same period.
- The company's operating profit declined by 64.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 364.5% in 3QFY18.
- Depreciation charges declined by 60.7% and finance costs declined by 9.3% YoY, respectively.
- Other income increased by 8575.0% YoY during the quarter.
- Net profit for the quarter increased by 75.2% YoY. Net profit margins during the quarter increased from -523.1% in 3QFY18 to -84.4% in 3QFY19.
Quarter-on-Quarter Performance:
- The company's operating income during the quarter fell 40.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.2% QoQ during the same period.
- The company's operating profit declined by 7.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 716.2% in 2QFY18.
- Net profit for the quarter increased by 19.6% QoQ, while net profit margins increased from -111.3% in 2QFY18 to -84.4% in 3QFY19.
To see how RELIGARE ENT. has performed over the last eight quarters, please visit here.
RELIGARE ENT. Share Price Performance
Over the last one year, RELIGARE ENT. share price has moved up from Rs 54.4 to Rs 19.6, registering a Loss of Rs 34.8 or around 63.9%.
Overall, the S&P BSE SENSEX is up 6.0% over the year.
Current Valuations
At the current price of Rs 19.6, the price to book value (P/BV) ratio of RELIGARE ENT. stands at 0.2 times.
|
| |
Related Views on News
RELIGARE ENT. 2017-18 Annual Report Analysis (Annual Result Update)
Dec 21, 2018 | Updated on Dec 21, 2018Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..
RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9% (Quarterly Result Update)
Nov 29, 2018 | Updated on Nov 29, 2018For the quarter ended September 2018, RELIGARE ENT. has posted a net profit of Rs 128 m (up 57.9% YoY). Sales on the other hand came in at Rs 13 m (down 50.7% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.
RELIGARE ENT. Announces Quarterly Results (4QFY18); Net Profit Up 27.2% (Quarterly Result Update)
Jun 4, 2018 | Updated on Jun 4, 2018For the quarter ended March 2018, RELIGARE ENT. has posted a net profit of Rs 643 m (up 27.2% YoY). Sales on the other hand came in at Rs 3 m (down 81.0% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.
CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)
Aug 7, 2018Should you apply to the IPO of CreditAccess Grameen Ltd?
HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)
Jul 20, 2018Should you subscribe to the IPO of HDFC AMC Ltd?
More Views on NewsMost Popular
Use My Secret to Increase Your Trading Profits Today
Dec 10, 2019What to do after every trade.
A Simple, 7-Step Checklist for Your Trading Success
Dec 4, 2019What we can learn from one of the greatest traders to have ever lived.
Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)
Dec 5, 2019This corner of the market could provide more returns than blue chips in 2020.
Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)
Dec 3, 2019Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)
Dec 2, 20192019 will be remembered as the year of great money-making IPOs...
More|
| |
RELIGARE ENT. SHARE PRICE
Dec 13, 2019 (Close)
TRACK RELIGARE ENT.
- Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON RELIGARE ENT.
RELIGARE ENT. - STC INDIA COMPARISON
COMPARE RELIGARE ENT. WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!